Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, January 19, 2022
Congenica, a digital health company enabling rapid and accurate analysis of complex genomic data has announced the expansion of its range of clinical consulting services. In addition to the services already offered by Congenica, the Company has ...
read more
Connie Wierman, a seasoned executive with more than 25 years of biopharmaceutical experience, has been named vice president of biopharmaceutical development for Theorem Clinical Research. She leads the company’s oncology therapeutic focus for the ...
read more
The gastrointestinal wall is a significant site of first-pass metabolism for oral drugs, which is commonly associated with CYP450 and UGT enzymes.
read more
Thursday, October 04, 2018
Consort Medical, Aesica CDMO Services, announces key facility updates for manufacturing and packaging solutions at both its Pianezza and Monheim sites.
read more
Tuesday, October 07, 2014
The Board of Consort Medical plc, today announced that it has agreed terms to acquire the entire issued and to be issued share capital of Aesica Pharmaceuticals Limited for £230 million. The closing of the transaction, which is expected to occur in ...
read more
Monday, February 09, 2015
Consort Medical plc (LSE: CSRT) (“Consort”, “Consort Medical” or the “Group”), a leading, global single source drug and delivery company, today announces the conclusion of a significant new commercial supply agreement for its proprietary integrated ...
read more
Tuesday, September 24, 2019
The Cell and Gene Therapy Catapult celebrates the completion of six additional modules at its manufacturing center in Stevenage.
read more
Decades of inaction to curb the overuse of life-saving antibiotics by physicians, dentists, patients, and farmers has created hard-to-treat "superbugs" that are spreading and growing stronger, with dire consequences, according to Consumer Reports.
read more
The global contract manufacturing market size is expected to reach USD 281.6 billion by 2026 registering a CAGR of 7.0%, according to a new report by Grand View Research, Inc. Increasing demand for advanced products is major factor driving the market...
read more
Contract Pharmacal plans to expand into a new space on Long Island, New York.
read more
Contract Pharmacal Corp has converted three of their buildings in the Hauppauge to run on solar energy.
read more
Friday, September 28, 2018
Pharmaceutical company Contract Pharmacal Corp. will invest $40 million to expand its operations in Hauppauge, New York.
read more
WCCT Global, a contract research organization headquartered in Southern California announced today the implementation of their new full service program for site feasibility and patient recruitment solutions. WCCT Global's "In-Site" patient ...
read more
Wednesday, December 14, 2016
ConverGene has entered into an exclusive license agreement with the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health. Under this agreement, ConverGene has the rights to commercialize jointly ...
read more
Wednesday, April 05, 2017
ConverGene has entered into a Collaborative Research and Development Agreement (CRADA) with the Molecular Neuropharmacology Section (MNS) of The National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health.
read more